New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Allogene Therapeutics, Inc. (ALLO) vs Rocket Pharmaceuticals, Inc. (RCKT)
- Allogene Therapeutics, Inc. ALLO 0.63 −5.97%
- Rocket Pharmaceuticals, Inc. RCKT 1.95 −7.58%
Allogene Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. are both Biotechnology companies. Allogene Therapeutics, Inc. and Rocket Pharmaceuticals, Inc. are of similar size ($235.6M and $231.1M). Across the 10 metrics below, Allogene Therapeutics, Inc. leads on 5 and Rocket Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | ALLO | RCKT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 70.18% |
| Operating margin | (342,700.00%) | — | 0.00% |
| Net margin | (335,973.56%) | — | 0.00% |
| Free cash flow margin | (261,473.56%) | — | 0.00% |
| Return on equity | (49.29%) | (5.04%) | (51.58%) |
| Return on assets | (36.69%) | (4.10%) | (45.91%) |
| Return on invested capital | (119.37%) | (111.24%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack